Form 8-K TG THERAPEUTICS, INC. For: Apr 15

Go back to Form 8-K TG THERAPEUTICS, INC. For: Apr 15

TG Therapeutics (TGTX) PT Lowered to $19 at Jefferies

April 19, 2022 8:36 AM EDT

Jefferies analyst Chris Howerton lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $19.00 (from $46.00) while maintaining a Buy rating.

The analyst commented, "During Monday morning's press conference TG announced it's pausing its oncology programs. The decision was made based on updated... More